[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353123-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-353123-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","transcriptomic-profiling-of-cutaneous-melanoma-metastases-treated-with-microwave-ablation-pilot-study","Transcriptomic Profiling of Cutaneous Melanoma Metastases Treated With Microwave Ablation - Pilot Study","","Microwave ablation delivers heating to tissue, enabling high-energy thermal cell death and potentially low-energy immune-stimulating effects without tissue necrosis. This pilot proof-of-concept study investigated transcriptomic changes in cutaneous melanoma metastases treated with directly applied microwave therapy. Seven adults with treatment-refractory skin metastases underwent morphological, histological, and tissue RNA sequencing. Complete responders showed increased inflammatory gene expression and reduced cancer markers versus baseline, while complete responders differed from partial responders by enriched FABP4 and lower cancer marker expression, supporting further clinical evaluation.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/transcriptomic-profiling-of-cutaneous-melanoma-metastases-treated-with-microwave-ablation-pilot-study/353123/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/transcriptomic-profiling-of-cutaneous-melanoma-metastases-treated-with-microwave-ablation-pilot-study/353123.png","ImageObject",300,407,{"name":42,"@type":43},"Jasmine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of the pilot study?","Question",{"text":63,"@type":64},"To determine whether directly delivered microwave therapy could reduce tumor volume and induce measurable molecular and transcriptomic changes in cutaneous melanoma metastases.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many patients were recruited, and how were responses assessed?",{"text":68,"@type":64},"Seven adult patients with skin metastases from malignant cutaneous melanoma were recruited, and responses were assessed using morphological, histological, and transcriptomic evaluation via tissue RNA sequencing.",{"name":70,"@type":61,"acceptedAnswer":71},"What transcriptomic differences were seen in complete responders?",{"text":72,"@type":64},"Compared with baseline, complete responders showed increased inflammation-related genes (e.g., CXCL5, CXCL8, IL1A, COL1A1) and downregulated cancer markers (e.g., PRAME, S100B, MLANA, STK32A).",{"name":74,"@type":61,"acceptedAnswer":75},"How did complete responders differ from partial responders?",{"text":76,"@type":64},"Complete responders showed enrichment of FABP4 and reduced expression of cancer markers relative to partial responders, consistent with stronger local tumor response.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},353123,1790226077,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,109,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},7,"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":148,"preview_page_count":33,"preview_urls":149},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Clinical and Translational Science  \nTranscriptomic Profiling of Cutaneous Melanoma  \nMetastases Treated With Microwave Ablation—Pilot Study  \nPurevsuren Losol1  | Daniel O'Driscoll2,3  | Andres Vallejo Pulido1  | Adrian von Witzleben1,4  |  \nKonstantinos Boukas2,5  | Matthew Sommerlad2,6 | Christian Ottensmeier1,7  | Michael R. Ardern-Jones1,2   \n1Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK | 2Department of Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK | 3Department of Dermatology, Imperial College Healthcare NHS Trust, London,  \nUK | 4Department of Otorhinolaryngology, Head and Neck Surgery, University of Ulm, Ulm, Germany | 5Wessex Investigational Sciences Hub, Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK | 6Department of Histopathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK | 7Faculty of Medicine, Liverpool Head and Neck Center, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK  \nCorrespondence: Michael R. Ardern-Jones ([m.aj@soton.ac.uk](m.aj@soton.ac.uk))  \nReceived: 20 January 2026 | Revised: 26 May 2026 | Accepted: 2 June 2026  \nKeywords: melanoma | microwave | transcriptomics | treatment  \nABSTRACT  \nMicrowave ablation induces heating of tissue. High energy results in thermal cell death, but low energy treatment without tissue necrosis has been shown to induce cutaneous immunity in an HPV wart model. It is approved as an effective cancer treatment for solid organ cancers, and therefore it is of interest to know if microwave delivered directly to the skin holds potential for treatment of skin cancer. This pilot study focused on transcriptomic profiling of cutaneous melanoma metastases to investigate molecular changes associated with microwave therapy. Seven adult patients with skin metastases from malignant cutaneous melanoma, not resolving on standard treatment, were recruited. Microwave energy was applied to separate melanoma metastases. Morphological, histological, and transcriptomic changes assessed via tissue RNA sequencing were evaluated. Three participants showed complete response, while four showed partial response by histological assessment. In complete responders, skin lesion RNA sequencing after treatment, compared with baseline, identified increased inflammation (CXCL5, CXCL8, IL1A, COL1A1) and downregulated cancer markers (PRAME, S100B, MLANA, STK32A). Compared with partial responders, complete responders showed enrichment ofFABP4 and reduced expression of cancer markers. Microwave therapy produced local tumor responses and associated inflammatory transcriptomic changes in complete responders, supporting further clinical evaluation in cutaneous melanoma metastases.  \n1 | Introduction  \nCutaneous melanoma is a malignant tumor arising from melanocytes, and historically, outcomes for those with advanced (stage III/IV) disease have been extremely poor; the five-year survival rate for untreated stage IV melanoma has been reported to be less than 10%[1]. Immune checkpoint inhibitor therapy for melanoma has led to a revolution in treatment, with 5-year survival on  \ncombination therapy exceeding 50%[2]. Nonetheless, half of patients do not respond to immunotherapy and therefore additional treatment strategies are needed [3]. Among these, electrochemotherapy with bleomycin or cisplatin achieves high local response rates (approximately 77%) with low toxicity [4, 5], making it effective for accessible cutaneous lesions. Similarly, talimogene laherparepvec (T-VEC) and intralesional interleukin-2 (IL-2) offer high local response rates and minimal systemic side effects [6–8].  \n\n| Purevsuren Losol and Daniel O'Driscoll contributed equally to this work. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and ","cbCaigm6Ga8LFQXR","https://ap.wps.com/l/cbCaigm6Ga8LFQXR","pdf",1216857,"English","# ABSTRACT\n# 1 | Introduction\n# Study Highlights","[{\"question\":\"What was the main goal of the pilot study?\",\"answer\":\"To determine whether directly delivered microwave therapy could reduce tumor volume and induce measurable molecular and transcriptomic changes in cutaneous melanoma metastases.\"},{\"question\":\"How many patients were recruited, and how were responses assessed?\",\"answer\":\"Seven adult patients with skin metastases from malignant cutaneous melanoma were recruited, and responses were assessed using morphological, histological, and transcriptomic evaluation via tissue RNA sequencing.\"},{\"question\":\"What transcriptomic differences were seen in complete responders?\",\"answer\":\"Compared with baseline, complete responders showed increased inflammation-related genes (e.g., CXCL5, CXCL8, IL1A, COL1A1) and downregulated cancer markers (e.g., PRAME, S100B, MLANA, STK32A).\"},{\"question\":\"How did complete responders differ from partial responders?\",\"answer\":\"Complete responders showed enrichment of FABP4 and reduced expression of cancer markers relative to partial responders, consistent with stronger local tumor response.\"}]","Transcriptomic Profiling of Cutaneous Melanoma Metastases Treated With Microwave Ablation - Pilot Study | PDF",1790103149,15,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/556468a8f549ab21a2a9cc6e5796a24c.webp",983,1291,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd107e270be71988dabac6ea3f6acca3.webp",982,1290,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d935cd1c254abcb7b3dbe4e342329473.webp",981,1289,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a10e0bb823b71cf8bcc5c4d80c342110.webp",980,1287]